Nanose Medical News
6 articles
growth-positive
Backed by Google, the EU, and the IIA, NaNose Medical is pioneering non-invasive, breath-based diagnostics to close the gap in early detection of liver and lung cancer. As it approaches its Series A, co-founder and COO Ilay Marom says the Israeli startup is already eyeing real-world deployment and commercialization.
NaNose Medical, an Israeli startup backed by Google, the EU, and the Israeli Innovation Authority, is pioneering non-invasive, breath-based diagnostics for early detection of liver and lung cancer. The company is preparing for its Series A funding round, aiming to commercialize its technology that uses AI to analyze breath biomarkers. Despite a setback due to geopolitical tensions, NaNose received emergency support from the Israel Innovation Authority and Google. The company focuses on addressing diagnostic blind spots in conditions like MASLD, which affects a significant portion of the global population. NaNoses technology, inspired by the human olfactory system, offers a cost-effective alternative to traditional methods, with the potential to enhance patient outcomes and penetrate the primary care market.
InvestmentProduct Stage
growth-positive
Ilay Marom, co-founder and COO of the startup NaNose Medical, was speaking on a panel held at Google and Calcalist’s Startup Week. Yair Levy, Brain.space: "I think Israel—its people and its tech ecosystem—has proven its resilience and creativity."
NaNose Medical, a startup specializing in early disease diagnosis through exhaled breath biomarkers, showcased its resilience during a panel at Google and Calcalist’s Startup Week. Despite the challenges posed by the October 7 crisis, the company managed to stabilize financially with grants from the European Union, Israel Innovation Authority, and Google. The team demonstrated extraordinary adaptability, advancing their development timeline despite disruptions. The panel emphasized the importance of resilience, adaptability, and choosing the right team members during times of uncertainty. NaNose Medical is currently in the clinical trial stage, collecting data in ten hospitals with promising results for diagnosing diseases like lung cancer.
Product StageInvestmentPartners
“Novel point-of-care, rapid breath test to identify patients with metabolicdysfunction associated steatotic liver disease with advanced fibrosis – a pilot study” – poster published at the EASL SLD Summit 2025
Find the abstract on page 37
growth-positive
ה"אף האלקטרוני" יציל חיים: החיישנים הננו-מטריים יתריעו על מחלות וזיהומים באמצעות הרחה בלבד
Nanose Medical, an Israeli company, is developing a diagnostic test that can detect diseases through breath analysis. The companys electronic nose technology is based on the principle that diseases have unique smells due to the release of specific volatile organic compounds (VOCs) from cells. The device collects a breath sample, exposes it to sensors, and then uses an algorithm to identify patterns in the electrical signals received. The company is currently in the development and clinical trial stage, with the first clinical trial conducted with three hospitals. The company believes that this non-invasive test could revolutionize the medical world by providing a cost-effective and efficient diagnostic tool.
InvestmentExpand
With a breath, Technion device finds lung cancer
growth-positive
Israeli Scientist Wins EU Innovation Award For Breath Test Device That Detects Diseases
Professor Hossam Haick of the Technion – Israel Institute of Technology has been awarded the European Commission Innovation Prize for his invention of the SNIFFPHONE, a device that uses nanotechnology sensors to analyse particles on the breath and diagnose diseases such as cancer and neurodegenerative diseases. The device includes the NaNose, a microchip developed in 2014 by Haick and Professor Nir Peled of Tel Aviv University’s Sackler Faculty of Medicine. In a 2017 study, the NaNose was able to differentiate between malignant and benign tumours, as well as their source, with almost 90% accuracy.
Investment
